Scrap All Barriers, Annual Drug Re-Pricing to Boost International Competitiveness of Japan Pharma: LDP’s Jimi

LDP’s Upper House Lawmaker Hanako Jimi Japan should remove all barriers hampering domestic pharma companies from expanding overseas if it is to bolster their global competitiveness, and annual drug price revisions “should absolutely be discontinued,” Liberal Democratic Party (LDP) lawmaker...read more